BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioNJ
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240513T073000
DTEND;TZID=America/New_York:20240517T170000
DTSTAMP:20260503T105003
CREATED:20231218T161943Z
LAST-MODIFIED:20231220T184516Z
UID:9936-1715585400-1715965200@bionj.org
SUMMARY:2024 BioPartnering Conference
DESCRIPTION:IN-PERSON PARTNERING\, EDUCATION & NETWORKING: Tuesday\, May 14\, 2024 | 7:30 a.m.-5:45 p.m.The Palace at Somerset Park\, Somerset\, NJ 08873Virtual Partnering: Monday\, May 13 & Wednesday-Friday*\, May 15-17\, 2024Registration for BioNJ Members is $425 and $525 for Future Members. *Full Conference Registration Required. \n\n\n\n\n\n\nBecome a Sponsor\n\n\n\n\n\n\n\n\nSave the date and plan to join us on May 14\, 2024 for BioNJ’s 14th Annual BioPartnering Conference\, the premier partnering event for entrepreneurs looking to connect with investors and biopharmaceutical companies for funding and collaboration opportunities.  \n\n\n\nOur new Conference location ― the Liberty Science Center ― offers a spacious\, state-of-the-art venue to accommodate the important and numerous elements of the Conference\, including: \n\n\n\n\n1-1 partnering\n\n\n\nCompany and start-up pitch presentations\n\n\n\nIndustry Connections (office hours with top biopharmaceutical companies)\n\n\n\nExhibits\n\n\n\nPlenary sessions\n\n\n\nAnd lots of networking\n\n\n\n\nBioNJ’s BioPartnering Conference attracts life sciences executives\, investors\, academic collaborators and business development professionals from around the globe ― with the goal of fostering productive partnerships and facilitating investment opportunities. \n\n\n\nApplications for Company Pitch Presentations for the 2024 BioNJ BioPartnering Conference will open January 16\, 2024. Be on the lookout for email notifications.
URL:https://bionj.org/event/2024-biopartnering-conference/
LOCATION:Liberty Science Center\, 222 Jersey City Blvd\, New Jersey\, 07305\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange,Past Event
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/12/BioP-Color.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240327T120000
DTEND;TZID=America/New_York:20240327T130000
DTSTAMP:20260503T105003
CREATED:20240220T153351Z
LAST-MODIFIED:20240315T150421Z
UID:10856-1711540800-1711544400@bionj.org
SUMMARY:Top Priorities for Life Sciences CFOs in 2024: A Life Sciences CFO Roundtable
DESCRIPTION:FREE Webinar: Top Priorities for Life Sciences CFOs in 2024: A Life Sciences CFO Roundtable \n\n\n\nQualifies for 1.0 CPE Credit in Specialized Knowledge. \n\n\n\nWednesday\, March 27\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin BioNJ and BDO on Wednesday\, March 27 for a roundtable discussion with life sciences CFOs about opportunities and risks facing the industry in 2024. \n\n\n\nThe webinar will discuss BDO’s 2024 Life Sciences CFO Outlook Survey\, which polled life sciences CFOs on their expectations for 2024. Below are some of the key issues this webcast will address. \n\n\n\n\nReview how life sciences CFOs are adjusting their cash management and investing strategies in response to ongoing economic volatility.\n\n\n\nDiscuss what tax strategies life sciences CFOs are pursuing to improve their financial standing — and what opportunities they may be missing.\n\n\n\nDescribe the treatments and drug modalities that life sciences CFOs will be prioritizing in 2024.\n\n\n\nExplain how life sciences organizations are addressing generative AI risks and concerns\, especially those related to data privacy.\n\n\n\n\nWho should attend: Private and Public Company Controllers\, Vice Presidents of Finance\, CFOs\, R&D Company CEOs\, Finance Team Members and Legal Counsel and others who are interested in the life sciences ecosystem. \n\n\n\nPanelists: \n\n\n\n\n\n\n\n\nAmit BhallaExecutive Vice President & Chief Financial Officer\, Sampled \n\n\n\nMr. Bhalla has more than 25 years of Wall Street and healthcare industry experience. His background in finance\, strategy and business development includes experience in equity investing as well as sourcing\, negotiating and integrating transformational and tuck-in M&A. Most recently\, Mr. Bhalla served as Senior Healthcare Analyst at Lord\, Abbett & Co. with responsibility for investments across all healthcare verticals in seven Lord Abbett funds. \n\n\n\n\n\n\n\n\n\nMike MaddenChief Financial Officer\, Lumanity \n\n\n\nMr. Madden is responsible for the Lumanity’s financial operations and functions. This includes financial strategy\, financial performance management\, capital allocation\, financial services\, controllership\, tax\, treasury and corporate strategy. Mr. Madden joined Lumanity in 2023 as an experienced finance leader\, with over 20 years of global finance and transformation experience. He possesses a proven track record of success with Fortune 250 financial institutions\, large multinational\, public\, and private equity backed companies. \n\n\n\n\n\n\n\n\n\nHarry PalminExperienced CFO \n\n\n\nMr. Palmin has a successful track record of building\, financing and operating public/private life sciences companies for 25 years\, having taken 3 companies public. He served as CFO at Acer Therapeutics from 2016 until the sale to Zevra Therapeutics in November 2023. Mr. Palmin took Acer public in 2017 achieving a $330 million peak market capitalization and raised $172 million in pursuit of Acer’s drug development and commercial objectives culminating in OLPRUVA® approval in December 2022. \n\n\n\n\n\n\n\n\n\nSarah RomanoCPA\, Chief Financial Officer\, First Wave BioPharma \n\n\n\nBefore joining First Wave BioPharma in March 2022\, Ms. Romano held the position of Chief Financial Officer at Kiora Pharmaceuticals\, a clinical-stage specialty pharmaceutical company focused on ophthalmic disease treatments\, from February 2017 to February 2022. Earlier\, she served as Corporate Controller at Kiora Pharmaceuticals from August 2016 to January 2017. Prior to that\, Ms. Romano worked as an Assistant Controller at TechTarget and as Corporate Controller at Bowdoin Group\, a healthcare-oriented executive recruitment firm. \n\n\n\n\n\n\n\n\n\nModerator \n\n\n\nDouglas E. Gustin\, CPAAssurance Principal\, BDO \n\n\n\nMr. Gustin has over 20 years of combined experience in public and private accounting working primarily with middle-market companies in technology\, manufacturing and life sciences industries. His client service experience includes working on SEC engagements\, including accelerated and large accelerated issuers as well as private equity\, venture backed and family-owned businesses. Mr. Gustin has extensive experience working with other BDO International member firms. \n\n\n\n\n\n\n\n\nThe life sciences industry is changing. Learn what opportunities and risks could await life sciences companies in 2024 and how to plan ahead. \n\n\n\nWe hope to see you on March 27\, 2024 for this FREE educational webinar.
URL:https://bionj.org/event/bdos-life-sciences-cfo-outlook-survey-live-sciences-resets-and-refocuses/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T120000
DTEND;TZID=America/New_York:20240306T130000
DTSTAMP:20260503T105003
CREATED:20240130T152008Z
LAST-MODIFIED:20240130T152134Z
UID:10742-1709726400-1709730000@bionj.org
SUMMARY:Integrating AI and Robotics to Discover New Drugs Faster
DESCRIPTION:FREE Webinar: Integrating AI and Robotics to Discover New Drugs Faster \n\n\n\nWednesday\, March 6\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this one-hour webinar where experts will use Iktos’ AI-driven platform to explore the synergy between artificial intelligence and robotics in the design and synthesis of novel molecules for drug discovery and optimization.  \n\n\n\nFrom handling diverse molecules\, reactions and exit vectors to optimizing reactants\, procedures and the number of steps\, this groundbreaking approach is poised to reshape the future of drug discovery.  \n\n\n\nBy streamlining research processes and addressing current weaknesses related to sub-optimal workflows and time-consuming manual tasks\, AI solutions have the potential to deliver a drug candidate within 24 months with just two chemists and one robot\, a significant reduction compared to the conventional requirement of 10 people and 30 months. \n\n\n\nInvite your entire Team to attend this FREE webinar\, including your scientists\, researchers\, R&D leads and business development professionals! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nQuentin Perron\, Ph.D.Co-Founder & Chief Scientific Officer\, Iktos \n\n\n\nAfter completing his post-doc fellowship at UCLA where Dr. Perron worked on the total synthesis of Brasillicardin A\, a complex natural molecule known for having a potent immunosuppressive activity\, he was a medicinal chemist in CNS indications at Laboratoires Servier. He later switched to data science and chemoinformatics at Quinten\, a company specialized in data science services. In 2016\, with his business partners Yann Gaston-Mathé and Nicolas Do Huu\, Dr. Perron co-founded Iktos\, a start-up company developing AI technologies for new drug design. \n\n\n\n\n\n\n\n\n\nFranck Le Vaillant\, Ph.D.\, MBASenior Scientist & Deputy Lab Head\, Iktos \n\n\n\nUpon completion of his Ph.D.\, Dr. Le Vaillant became a SNF-postdoctoral fellow to the Max-Planck-Institute für Kohlenforschung in Mülheim an der Ruhr where he developed Ni-catalyzed C-O bond formations using nitrous oxide. He later started the Labcom HitCat\, a joint lab between the company Seqens and the group of Prof. Géraldine Masson (CNRS). Dr. Le Vaillant joined Iktos in July 2022\, where he works on the installation\, development and utilization of the Iktos Robotics Platform for Drug Discovery. \n\n\n\n\n\n\n\n\nWe hope to see you on March 6\, 2024 for this FREE educational webinar.
URL:https://bionj.org/event/integrating-ai-and-robotics-to-discover-new-drugs-faster/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T164500
DTEND;TZID=America/New_York:20240208T213000
DTSTAMP:20260503T105003
CREATED:20231129T132752Z
LAST-MODIFIED:20241120T151605Z
UID:9813-1707410700-1707427800@bionj.org
SUMMARY:2024 BioNJ Annual Dinner Meeting & Innovation Celebration
DESCRIPTION:Thursday\, February 8\, 2024 | 4:45 p.m.-9:30 p.m. | Hilton East Brunswick\n\n\n\n\nBecome a Sponsor\n\n\n\nPhoto Gallery\n\n\n\n\nWe are excited to share that due to popular demand\, BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration is sold out! Thank you to everyone who has registered to attend tomorrow’s celebration. We look forward to paying tribute to New Jersey’s extraordinary life sciences ecosystem and the Patients who inspire us. Registration is now closed and we are unable to accommodate walk-ins. We apologize for any inconvenience. Please contact BioNJ at 609-890-3185 with any questions. Thank you for your support and understanding. \n\n\n\n\n\n\n\nJoin us for BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration\, taking place Thursday\, February 8\, 2024\, at the Hilton East Brunswick\, where we’ll celebrate the extraordinary innovation happening in the Garden State.   \n\n\n\nMany surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year\, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:  \n\n\n\n\nNetworking with biopharmaceutical professionals\, government officials\, academic leaders and professional service providers\n\n\n\nThe presentation of the Dr. Sol J. Barer Award for Vision\, Innovation and Leadership by Dr. Barer himself to William H. Lewis\, J.D.\, MBA\, Chair and CEO of Insmed\n\n\n\nAn inspirational Spoken Word by Lupus Warrior Shanelle Gabriel\n\n\n\nThe acclaimed Innovator Awards honoring New Jersey companies that received a new FDA drug approval in 2023\n\n\n\nThe presentation of the Heart of BioNJ Awards to Lisa Salberg\, Founder & CEO\, Hypertrophic Cardiomyopathy Association; Amadou Diarra\, Ph.D.\, Senior Vice President\, Global Policy\, Advocacy & Government Affairs\, Bristol Myers Squibb and Mark Peters\, Senior Director\, Patient Advocacy\, Genmab \n\n\n\nA special Keynote honoring Patients around the world\n\n\n\nA Cocktail Hour\, Dinner Program and Dessert Reception\n\n\n\n\nDon’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $500 and $575 for Future Members. Reserve a table for your Team today.  \n\n\n\nThe 2024 Innovator Award Honorees Include:  \n\n\n\n\n\n\nAbbVie \n\n\n\nAcrotech Biopharma \n\n\n\nAmicus Therapeutics \n\n\n\nAcadia Pharmaceuticals \n\n\n\nBausch + Lomb\n\n\n\nBristol Myers Squibb \n\n\n\nCorMedix Inc. \n\n\n\nDaiichi Sankyo \n\n\n\nEisai \n\n\n\nEli Lilly \n\n\n\nEvive Biotech \n\n\n\nGamida Cell\n\n\n\nGC Biopharma USA \n\n\n\nGenmab\n\n\n\nGSK \n\n\n\nIpsen\n\n\n\n\n\n\n\nIveric BIO\n\n\n\nJohnson & Johnson\n\n\n\nLexicon Pharmaceuticals\n\n\n\nMelinta Therapeutics \n\n\n\nNestlé Health Science \n\n\n\nNovartis\n\n\n\nNovo Nordisk \n\n\n\nOctapharma\n\n\n\nProtalix Biotherapeutics\n\n\n\nPfizer \n\n\n\nPharming \n\n\n\nRegeneron\n\n\n\nSanofi \n\n\n\nPlus\, Boehringer Ingelheim Animal Health USA and Zoetis for FDA Animal Drug Approvals\n\n\n\n\n\n\n\n\n\n\n\n\n\nContact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities\, reserve a table and to place your organization in the spotlight. 
URL:https://bionj.org/event/2024-annual-dinner-meeting-innovation-celebration/
LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240118T120000
DTEND;TZID=America/New_York:20240118T130000
DTSTAMP:20260503T105003
CREATED:20231212T181900Z
LAST-MODIFIED:20231218T194037Z
UID:9888-1705579200-1705582800@bionj.org
SUMMARY:How End-User Adoption is Key to Software Deployment Success
DESCRIPTION:FREE Webinar: How End-User Adoption is Key to Software Deployment Success \n\n\n\nThursday\, January 18\, 2024 | 12:00 p.m.-1:00 p.m. \n\n\n\n\nRegister Today for FREE!\n\n\n\n\nJoin us for this intimate discussion with industry leaders on best practices to ensure end-user adoption in software project deployment. Topics to be covered include: \n\n\n\n\nUsing an MVP (Minimum Viable Product) strategy under the guidance of a seasoned business analyst to meet crucial end-user requirements.\n\n\n\nEmploying Agile methodology for continuous feedback and improvement.\n\n\n\nControlling scope and managing expectations through phased rollouts.\n\n\n\nReflecting on past challenges and successes.\n\n\n\n\nInvite your entire Project Team to attend this FREE webinar\, created for project managers\, business analysts\, engineering\, IT end-users\, operators\, scientists and more! \n\n\n\nSpeakers: \n\n\n\n\n\n\n\n\nAnthony DeJohnDirector\, Systems & Software SolutionsControl Associates \n\n\n\nMr. DeJohn boasts a successful 30-year career in process control\, digital manufacturing and process data analytics technologies\, establishing himself as a prominent process automation leader.  Passionate about manufacturing excellence\, digital tools\, and leveraging data from the shop floor to enterprise systems\, Mr. DeJohn remains at the forefront of innovation in the industry. \n\n\n\n\n\n\n\n\n\nPaula HudsonSenior Lab Systems ArchitectThermo Fisher Scientific \n\n\n\nMs. Hudson has accumulated over 20 plus years’ experience as a concept-to-launch project manager\, application designer\, data analyst\, database architect and application support expert. Through her work at universities and with one of the largest pharmaceutical manufacturers in the world\, she is recognized for her ability to guide impactful change.  \n\n\n\n\n\n\n\n\n\nSusanne BrownVice President\, Program ManagementInsmed \n\n\n\nMs. Brown works with a team of talented program managers to support and drive excellence in drug development bringing new promising medications to Patients.  After spending time in the microbiology lab and running clinical development programs\, she decided to dedicate her career in all avenues of project\, program\, resource and portfolio management. Prior to Insmed\, Ms. Brown held various roles at several large pharmaceutical and Healthcare companies \n\n\n\n\n\n\n\n\nWe hope to see you on January 18\, 2024 for this FREE educational webinar.
URL:https://bionj.org/event/how-end-user-adoption-is-key-to-software-deployment-success/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231207T120000
DTEND;TZID=America/New_York:20231207T130000
DTSTAMP:20260503T105003
CREATED:20231031T140557Z
LAST-MODIFIED:20231115T153551Z
UID:9584-1701950400-1701954000@bionj.org
SUMMARY:BioNJ Health Equity in Clinical Trials Best Practices Webinar
DESCRIPTION:BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Designing Trials to Broaden Reach and Expand Diversity\n\n\n\nThursday\, December 7\, 2023 | 12:00 p.m. –  1:00 p.m. | Free Webinar\n\n\n\n\nRegister Today!\n\n\n\nHealth Equity in Clinical Trials Best Practices Database\n\n\n\n\nBioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end\, we are pleased to announce the second webinar in BioNJ’s Health Equity in Clinical Trials Best Practices Webinar Series. Please join us on Thursday\, December 7\, from 12:00 p.m. to 1:00 p.m.\, as three industry experts share case studies on methods and techniques which their organizations use to “Broaden Reach and Expand Diversity in Clinical Trials.” \n\n\n\nPresenters include: \n\n\n\n\n\n\n\n\nMichel Reid\, Senior Director and Head\, Global Demographics & Diversity for GSK\, will present on My Living Legacy\, created in partnership with the Tigerlily Foundation to empower Black and other BIPOC people to more deeply understand and trust in clinical trials and to consider clinical trials as a possible treatment option for life-threatening diseases like breast cancer. Mr. Reid will also share how GSK partnered with MiOrato ensure that women from underserved communities are represented in clinical trials for Ovarian Cancer by training public health student in socioeconomically disadvantaged neighborhoods to become community health educators.  \n\n\n\n\n\n\n\n\n\nThe FDA defines a decentralized clinical trial as a clinical investigation where some or all of the trial-related activities occur at a location separate from the investigator’s location. Today’s technologies let Patients remotely engage with trial activities\, creating better Patient experiences and letting sponsors execute faster trials – driven by high-quality data. Kelly McKee\, Vice President\, Decentralized Clinical Trials\, for Medidata\, will present on how to use decentralized trialsto broaden reach and improve Patient\, site and sponsor experiences. Using a case study\, Ms. McKee will explore what decentralized clinical trials mean for all stakeholders\, including biopharmaceutical companies. \n\n\n\n\n\n\n\n\n\nSunanda Gaur\, M.D.\, Director of the Clinical Research Center at Rutgers Robert Wood Johnson Medical School\, will share valuable insights into Rutgers’ four-year study on the long-term and delayed impacts of COVID-19 in children. Encompassing more than 2\,000 participants\, across 14 sites\, Dr. Gaur will discuss Rutgers’ community-facing strategy\, including bi-lingual recruitment leads\, used for trial enrollment. Additionally\, Dr. Gaur will elaborate on the decentralize component of the trial to ensure inclusion of diverse populations.  \n\n\n\n\n\n\n\n\nRegister for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and ensure that “No Patient is ever left behind“.
URL:https://bionj.org/event/bionj-health-equity-in-clinical-trials-best-practices-webinar-2/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231201T083000
DTEND;TZID=America/New_York:20231201T150000
DTSTAMP:20260503T105003
CREATED:20230717T182336Z
LAST-MODIFIED:20231129T122115Z
UID:7820-1701419400-1701442800@bionj.org
SUMMARY:2023 Inspiring Women in STEM Conference
DESCRIPTION:Empowering Brilliance & Resilience for Long-Term Success\n\n\n\nFriday\, December 1\, 2023 | Sanofi U.S.\, 55 Corporate Drive\, Bridgewater\, NJ \n\n\n\nJoin us for BioNJ’s Ninth Annual Inspiring Women in STEM Conference on Friday\, December 1\, 2023. The action-packed schedule features forward-thinking presentations\, informative panel discussions\, audience participation exercises and quality networking.  \n\n\n\nMore timely than ever\, attendees are sure to come away with valuable and actionable ideas and guidance! \n\n\n\n\n\n\n\n\nDon’t Miss This Special Keynote \n\n\n\nBe UNFORGETTABLE: How to Position Yourself for Success \n\n\n\nPresented by Alessandra Wall\, Ph.D.\, Executive Coach\, Speaker\, Founder\, Noteworthy \n\n\n\n﻿Imagine stepping into any situation and feeling 100% confident in your ability to articulate your value and the impact you can make for your team\, your company\, a client or a prospective employer. This keynote explores three fail-proof strategies to position yourself to do more of what you excel at and love. You will discover a process to confidently share your areas of excellence with others and help them understand the impact you can make for them and your organizations. You’ll develop a blueprint to speak up\, own your power and value and share it with others without guilt or unease ― and become UNFORGETTABLE! \n\n\n\n\n\n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\n\n\n\nClick here or contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions.  
URL:https://bionj.org/event/2023-inspiring-women-in-stem-conference/
LOCATION:Sanofi\, Sanofi Building D\, Corporate Dr\, Bridgewater Township\, NJ\, 08807
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/07/IWSTEM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231116T083000
DTEND;TZID=America/New_York:20231116T141500
DTSTAMP:20260503T105004
CREATED:20230809T152945Z
LAST-MODIFIED:20230918T163650Z
UID:8176-1700123400-1700144100@bionj.org
SUMMARY:2023 BioNJ Patient Advocacy Summit
DESCRIPTION:Thursday\, November 16\, 2023\, 8:30 a.m.-2:15 p.m.\n\n\n\nBristol Myers Squibb • 3551 Lawrenceville Rd\, Princeton\, NJ 08540 \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nIn its eighth year\, BioNJ’s Patient Advocacy Summit is taking place November 16 at Bristol Myers Squibb. With topics requested by the Patient advocacy community\, we hope you join us for this important conversation! Please check out the agenda below and click here to register. \n\n\n\nThe Summit will bring together Patients\, Patient Advocacy Groups\, Caregivers\, Clinicians and R&D Professionals for a day of Education\, Engagement and Empowerment. Attendees will gain valuable tools and insights\, share best practices and meet key stakeholders within the health care ecosystem.  \n\n\n\nJoin us for this dynamic and educational discussion that will leave us all inspired and armed with new tools to make a difference on behalf of Patients! \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nA must attend program for anyone who advocates on behalf of Patients! Click here to register! Attendance is open and free to ALL Patient Advocacy Groups and R&D company Patient advocacy and government affairs professionals.  \n\n\n\nPlus\, if you are unable to attend in person\, and are interested in watching a live streamed version of the event\, please contact Randi Bromberg at RBromberg@BioNJ.org.
URL:https://bionj.org/event/2023-bionj-patient-advocacy-summit/
LOCATION:Bristol Myers Squibb\, 3551 Lawrenceville Rd\, Princeton\, New Jersey\, 08540\, United States
CATEGORIES:BioNJ Event
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/BioNJ_PPA-Summit_Logo_copy-copy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231101T130000
DTEND;TZID=America/New_York:20231101T180000
DTSTAMP:20260503T105004
CREATED:20230828T175346Z
LAST-MODIFIED:20231003T201630Z
UID:8643-1698843600-1698861600@bionj.org
SUMMARY:2023 AI & Digital Health Day
DESCRIPTION:Wednesday\, November 1\, 2023 • 1:00 p.m. – 6:00 p.m. \n\n\n\n340 Mt. Kemble Ave\, Morristown \n\n\n\n\nRegister Today\n\n\n\nBecome a Sponsor\n\n\n\n\nAI is rapidly changing the way we do things in the workplace\, and the impact in the life sciences industry has been both rapid and significant. BioNJ\, in partnership with Morgan Stanley\, will host its inaugural BioNJ AI & Digital Health Day on November 1. \n\n\n\n﻿Join us for this important program which will: \n\n\n\n\nHighlight emerging trends within the life sciences industry\n\n\n\nProvide access to investors\, thought leaders and experts for advice and guidance\n\n\n\nAddress some of the challenges that entrepreneurs face as they create innovative AI and digital health solutions to improve Patient outcomes\n\n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nSPACE IS LIMITED! Register today and join an audience of entrepreneurs and industry professionals that support the life sciences and digital health ecosystem for this timely and informative discussion. Registration is $25 for BioNJ Members and $35 for Future Members. Click here to register. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities.
URL:https://bionj.org/event/2023-ai-digital-health-day/
LOCATION:Morgan Stanley\, 340 Mt. Kemble Ave.\, New Jersey\, 07960\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/AI-Digital-Health-Color-With-Sponsors-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T090000
DTEND;TZID=America/New_York:20231026T160000
DTSTAMP:20260503T105004
CREATED:20230810T164457Z
LAST-MODIFIED:20230901T134049Z
UID:8202-1698310800-1698336000@bionj.org
SUMMARY:INDUSTRY EVENT: BioLabs Investor Day 2023 Princeton
DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\n\nBioLabs is planning an Investor Day on Thursday\, October 26\, from 9 am to 4 pm\, with the goal of bringing a wide range of investors to Princeton for a day of pre-selected lightning pitches\, a panel discussion and invite-only networking.  \n\n\n\nBioLabs held successful Investor Day events at our sister sites in Heidelberg\, Germany\, and Philadelphia\, Pennsylvania\, including an event in Chicago\, Illinois\, as well. These events helped make connections across the life science community at a time when it matters more than ever — featuring 10–30 pitches and 25–30 investors per event. The Princeton event will target an invite-only audience of >100 select attendees.   \n\n\n\nIf interested in attending\, please fill out this form.  \n\n\n\nJoin us in bringing our winning formula to Princeton on October 26!
URL:https://bionj.org/event/biolabs-investor-day-2023-princeton/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231026T090000
DTEND;TZID=America/New_York:20231026T120000
DTSTAMP:20260503T105004
CREATED:20230717T180640Z
LAST-MODIFIED:20231024T175020Z
UID:7818-1698310800-1698321600@bionj.org
SUMMARY:2023 IT/Cybersecurity Breakfast Briefing
DESCRIPTION:Navigating the Digital Frontier: Empowering Your Cybersecurity Journey\n\n\n\nThursday\, October 26 2023 • 9:00 a.m. – 12:00 p.m.Fox Hollow Golf Club\, 59 Fox Chase Run\, Branchburg\, NJ 08876\n\n\n\n \n\n\n\n\nRegister Now\n\n\n\nBecome a Sponsor\n\n\n\n\nThe life sciences industry continues to be a top target for cyber criminals. So much so that bad cyber actors are infiltrating the unintended IT weaknesses of the 3rd-party vendor community that is so supportive of life sciences companies.  \n\n\n\nWhether a life sciences company is pre-revenue\, early-revenue or mature\, this 3rd-party vendor vulnerability puts all data at risk\, including\, but not limited to\, data related to patients\, research\, intellectual property and M&A.  \n\n\n\nTo help address this and other cybersecurity challenges\, please join us at Fox Hollow Golf Club in Branchburg on October 26th for a BioNJ IT/Cybersecurity Awareness Breakfast Briefing. We will network\, have breakfast and hear from the FBI and other experts about practical and cost-effective tips to better protect your organization’s data. \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nDiscounted golf is offered after the program. 9 holes of golf with a cart available for $30 per golfer. Tee-time reservations are required. To make a reservation call (908)-526-0010\, Ext. 102. \n\n\n\n\n\n\nRegistration is $75 for BioNJ Members and $95 for Future Members. If you would like to learn about Sponsorship Opportunities\, please contact Cheri Hennessy at CHennessy@BioNJ.org. 
URL:https://bionj.org/event/2023-it-cybersecurity-breakfast-briefing/
LOCATION:Fox Hollow Golf Club\, 59 Fox Chase Run\, Branchburg\, New Jersey\, 08876\, United States
CATEGORIES:BioNJ Event
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/IT-Cyber.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231019T120000
DTEND;TZID=America/New_York:20231019T131500
DTSTAMP:20260503T105004
CREATED:20230922T152558Z
LAST-MODIFIED:20231016T110144Z
UID:9056-1697716800-1697721300@bionj.org
SUMMARY:2023 Finance Webinar
DESCRIPTION:Bridging Science and Finance: Practical Uses of AI\n\n\n\nThursday\, October 19\, 2023 • 12:00 p.m. – 1:15 p.m. • Virtual\n\n\n\n\nRegister Now\n\n\n\n\nJoin us for a dynamic webinar that delves into the role of AI in financial operations in life sciences. We’ll explore how technologies are reshaping financial strategies and decision-making as well as hear about real-life examples. Gain insights into the evolving landscape of AI-driven finance while discovering key trends\, challenges and opportunities that are driving financial innovation. We’ll hear about best practices in leveraging AI and the benefits it can provide to finance teams and the organization as a whole to achieve financial excellence in life sciences. \n\n\n\nPanel of Experts: \n\n\n\n\n\n\n\nWhether you’re a financial professional\, a life sciences executive or simply curious about the future of finance in the healthcare sector\, this free webinar offers a unique opportunity to gain knowledge and inspiration on the benefits AI can offer from industry experts. Don’t miss your chance to be a part of this enlightening conversation at the intersection of finance\, AI and medical innovation. Click here to register at no cost.
URL:https://bionj.org/event/2023-finance-webinar/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/07/IWSTEM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231015T000000
DTEND;TZID=America/New_York:20231018T235959
DTSTAMP:20260503T105004
CREATED:20230711T134325Z
LAST-MODIFIED:20230901T134017Z
UID:7733-1697328000-1697673599@bionj.org
SUMMARY:Winds of Change 2023
DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\n\nThe LES USA & Canada 2023 Annual Meeting will take place at the trendy Chicago Marriott Downtown Magnificent Mile\, October 15-18\, 2023. Under the theme of Winds of Change: Dealmaking Trends in the Evolving Innovation Economy\, our dynamic international IP community will meet in Chicago for two action-packed days of education\, outstanding programming\, and networking\, with global dealmaking opportunities.  \n\n\n\nThe 2023 Annual Meeting will include distinguished keynotes and fireside chats along with forward-looking topics\, ranging from advances in healthcare\, smart manufacturing\, innovations in fintech\, and IP valuation in the new era of licensing. Join interactive roundtable discussions or the partnering hub to expand your business network! \n\n\n\nRegister today and reconnect with friends and peers over coffee\, make new contacts during networking events and receptions and so much more at the LES 2023 Annual Meeting. \n\n\n\nLearn more and register.
URL:https://bionj.org/event/winds-of-change/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231012T100000
DTEND;TZID=America/New_York:20231012T113000
DTSTAMP:20260503T105004
CREATED:20231003T143822Z
LAST-MODIFIED:20231003T145410Z
UID:9120-1697104800-1697110200@bionj.org
SUMMARY:Road to Commercialization Symposium Series: Communicating with Impact and the Art of Storytelling
DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\nRutgers Office for Research extends our invitation to the NJ researchers and entrepreneurs ecosystem to join us on Thursday\, Oct 12\, from 10 am-11.30 am (EST) for our Road to Commercialization Webinar\, Communicating with Impact: The Art of Storytelling. Hear from keynote speakers Otto Pohl and Dena Seidel who will share their expertise\, do’s and don’ts and tested framework/s to help us tell the story of our research effectively and in a way that is meaningful to industry and investors and others listening to it. To learn more about this webinar\, click here. Feel free to share with anyone you think might be interested as this event is open to all.
URL:https://bionj.org/event/road-to-commercialization-symposium-series-communicating-with-impact-and-the-art-of-storytelling/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231006T073000
DTEND;TZID=America/New_York:20231006T160000
DTSTAMP:20260503T105004
CREATED:20230221T141436Z
LAST-MODIFIED:20231005T125458Z
UID:6712-1696577400-1696608000@bionj.org
SUMMARY:2023 BioNJ C-Suite Summit
DESCRIPTION:Registration for the C-Suite Summit is closed.  Please contact BioNJ Headquarters at 609-890-3185 with any questions or to be added to a wait list. \n\n\n\n\n\n\n\nChasing Breakthrough Innovation in a Time of UncertaintyWith Insights from McKinsey & Company\n\n\n\nFriday\, October 6\, 2023 • 7:30 a.m.-4:00 p.m.Bridgewater Marriott\, 700 Commons Way\, Bridgewater\n\n\n\n\nBecome a Sponsor\n\n\n\n2022 Attending Companies\n\n\n\n\nWe are facing a period of discontinuous change marked by the ever-accelerating AI revolution and advancements in therapeutics ― set against the backdrop of increasing lifecycle compression (exacerbated by the Inflation Reduction Act)\, a tumultuous fundraising environment\, and growing macroeconomic uncertainty. \n\n\n\nJoin BioNJ and industry leaders on October 6 to explore the implications of these evolutions\, with a focus on the trajectory of breakthrough innovation. In addition to timely topics\, such as a futuristic look at innovation\, reimagining the biopharma workforce and the transformative impact of technology and AI on the industry\, be on hand for these Keynotes… \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nClick here to register. Registration is $695 for BioNJ Members and $895 for future BioNJ Members. BioNJ’s C-Suite Summit brings together more than 200 life sciences executives ― representing a wide breadth of companies from early to late-stage\, public and private and revenue and pre-revenue ― for networking and timely discussions on what’s impacting C-Suite decision-making in bringing new innovation to market. \n\n\n\nSponsorship opportunities are now available. Contact Cheri Hennessy at CHennessy@BioNJ.org to learn more.
URL:https://bionj.org/event/bionj-c-suite-summit/
LOCATION:Bridgewater Marriott\, 700 Commons Way\, Bridgewater\, New Jersey\, 08807\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/02/CSuite-Summit-2023.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230928T170000
DTEND;TZID=America/New_York:20230928T190000
DTSTAMP:20260503T105004
CREATED:20230817T182243Z
LAST-MODIFIED:20230901T133733Z
UID:8494-1695920400-1695927600@bionj.org
SUMMARY:Science Matters: New Jersey Newcomers Blazing Trails
DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\nRegister
URL:https://bionj.org/event/science-matters-new-jersey-newcomers-blazing-trails/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230927T090000
DTEND;TZID=America/New_York:20230927T100000
DTSTAMP:20260503T105004
CREATED:20230901T120503Z
LAST-MODIFIED:20230925T162839Z
UID:8711-1695805200-1695808800@bionj.org
SUMMARY:Webinar: The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven\, Compliant\, Equitable\, Connected Healthcare Ecosystem
DESCRIPTION:The Technology Revolution in Healthcare is in Sight: Realizing an AI-driven\, Compliant\, Equitable\, Connected Healthcare Ecosystem\n\n\n\nWednesday\, September 27\, 2023 ● 9:00 a.m.-10:00 a.m.\n\n\n\n\nRegister Today\n\n\n\n\nThe speed of innovation and acceleration in healthcare is nothing like we have ever seen before. The industry was picking up speed prior to the COVID-19 pandemic and since then we have seen an acceleration in everything from telemedicine\, to decentralized clinical trials\, to AI applied to everything from drug discovery to commercialization. That leaves us both with an amazing opportunity to solve some of the greatest healthcare challenges but also brings new complexities and issues we need to tackle from a privacy\, security\, legal and ethical standpoint. It will take everyone to both realize the potential and ensure we move forward in a measured and responsible way that does not hold back the very innovation that will save lives – why we all do what we do every day! \n\n\n\nJoin BioNJ and industry leaders on September 27 to dive into these topics with a focus on how we can all start to apply new technologies even in the smallest ways to make progress forward in what will prove to be one of the most dynamic eras of healthcare ahead.  \n\n\n\n\n\n\n\n\n Reed Abrahamson\, Partner\, Faegre Drinker \n\n\n\nAs a member of Faegre Drinker’s FDA Regulatory Team\, Reed advises clients in the life sciences industry\, including major pharmaceutical\, biotechnology and medical device companies\, on a wide range of issues associated with clinical trials and research. He assists in the development and negotiation of clinical trial agreements\, informed consent forms and other important research documents. Additionally\, Reed supports companies as they contract with research vendors and collaboration partners\, as well as helps companies implement privacy and security measures to support clinical trials and medical research. \n\n\n\n\n\n\n\n\n\n Lynne Anderson\, Partner\, Faegre Drinker \n\n\n\nLynne has a long history of working with life sciences/pharmaceutical clients. She is an experienced jury and bench trial lawyer with a track record of success in whistleblower/retaliation cases\, discrimination claims\, wage and hour class/collective actions and restrictive covenant disputes. Lynne’s litigation background provides the insight to effectively counsel clients who are dealing with strategic planning and frontline employee issues. She is Co-Chair of the BioNJ’s HR Committee and founding member and Co-Chair of BioNJ’s Inspiring Women of STEM Committee. \n\n\n\n\n\n\n\n\n\n Romain Bogaerts\, Director\, AI Product Management\, Real Chemistry \n\n\n\nRomain’s team builds both internal facing AI solutions and external AI products for life sciences companies. Internally\, the team has developed a Generative AI platform and other AI algorithms that empower the agency side of Real Chemistry to become exponentially more insightful. For clients\, Romain leads the design and development of innovative products: AdTech capabilities for Swoop to target the right Patient and HCP audiences\, HealthTech products at ipm.ai to identify undiagnosed Patients in specialty and MarTech data products that link SDOH and social media data to measure the impact of campaigns.  \n\n\n\n\n\n\n\n\n\n Jennifer Gottlieb\, Global President\, Chief Client Officer\, Real Chemistry \n\n\n\nJennifer is the Global President\, Chief Client Officer and member of the Board of Directors of Real Chemistry\, the leading provider of AI-driven insights and human-centric experiences for the healthcare industry. A healthcare pioneer — Jennifer’s career has been dedicated to driving strategic communications and commercial initiatives for clients in the pharmaceutical and biotechnology sectors as they navigate the ever-changing industry landscape. Jennifer takes on bold challenges\, including realizing the company’s vision to use AI and Ideas to transform the healthcare experience from what it is to what it should be. \n\n\n\n\nWe hope to see you on September 27 for this FREE educational webinar!
URL:https://bionj.org/event/webinar-the-technology-revolution-in-healthcare-is-in-sight-realizing-an-ai-driven-compliant-equitable-connected-healthcare-ecosystem/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/09/Webinar-Banner-Faegre.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230925T000000
DTEND;TZID=America/New_York:20230927T235959
DTSTAMP:20260503T105004
CREATED:20230726T181257Z
LAST-MODIFIED:20230901T133736Z
UID:7942-1695600000-1695859199@bionj.org
SUMMARY:Life Sciences Palooza 2023
DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\nPlay your cards right and join us at Life Sciences Palooza 2023!\n\n\n\nJoin valued customers from RLDatix Life Sciences\, including Porzio Life Sciences\, iContracts\, and iCoachFirst. You’ll gain the insight and inspiration you need to take your initiatives to the next level. \n\n\n\nTaking place from the afternoon of September 25th through 27th at the Hard Rock Hotel in Atlantic City\, we will provide a robust schedule of thought-provoking keynotes\, immersive hands-on discussion points\, lively evening networking activities and so much more.  \n\n\n\nHIGHLIGHTS: \n\n\n\n\nOverview of current Industry Trends\n\n\n\nBest Practices for Reporting\, Analyzing Data\, Integrating Compliance\, and more…\n\n\n\nProduct-Specific Breakout Groups\n\n\n\nFun\, Games\, and Surprise Guests!\n\n\n\n\nQuestions? Contact Lexi (Harris@porziols.com) or Kristen (kabrahamsen@icontracts.com).  \n\n\n\n\nRegister
URL:https://bionj.org/event/life-sciences-palooza-2023/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230921T123000
DTEND;TZID=America/New_York:20230921T133000
DTSTAMP:20260503T105004
CREATED:20230804T105609Z
LAST-MODIFIED:20230924T130445Z
UID:8037-1695299400-1695303000@bionj.org
SUMMARY:BioNJ Health Equity in Clinical Trials Best Practices Webinar
DESCRIPTION:BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration\n\n\n\nThursday\, September 21\, 2023 • 12:30 p.m.-1:30 p.m. | Free Webinar\n\n\n\n\nRegister Today!\n\n\n\nHealth Equity in Clinical Trials Best Practices Database\n\n\n\n\nBioNJ has been working passionately to increase health equity in clinical trials over the past 18 months. To that end\, we are pleased to announce the highly anticipated next phase of our work in a series of programs where life sciences professionals can share their health equity in clinical trials initiatives\, ask questions and explore possible collaboration opportunities. \n\n\n\nOn the heels of our recently debuted Best Practices Database featuring a diverse array of initiatives being offered by the community\, please join us virtually on Thursday\, September 21\, from 12:30 p.m. to 1:30 p.m.\, for BioNJ’s Health Equity in Clinical Trials Best Practices Webinar: Examples from Which to Learn & Opportunities for Collaboration. Click here to register for FREE. \n\n\n\nLearn about three innovative initiatives which have the potential to be game changers: \n\n\n\n\n\n\n\n\n Bristol Myers Squibb \n\n\n\nIn looking beyond race and ethnicity\, Bristol Myers Squibb (BMS) is partnering with its Employee Resource Groups to explore diversity in clinical trials as it impacts other groups. Sharon Hanlon\, Head of Clinical Trials Engagement and Enrollment\, will discuss two recent BMS initiatives: “SOGIIS Data Collection Patients” which gives Patients the option to report demographic information relevant to their sexual orientation and gender identity and a “Clinical Trials Implications Assessment for Disabled Patients” which journey maps the clinical trial experience for disabled Patients\, identifying opportunities for growth. \n\n\n\n\n\n\n\n\n\n Novartis & U.S. Novartis Foundation \n\n\n\nNovartis and the U.S. Novartis Foundation have taken a major step forward in addressing the root causes of disparities in health and education with Beacon of Hope – a 10-year commitment to co-creating programs that address health and education inequities and create greater diversity\, equity\, inclusion and trust across the research and development ecosystem. Dr. Linda Armstrong\, Head of U.S. Corporate Responsibility and President of U.S. Novartis Foundation\, will provide an overview of this first-of-its-kind innovative collaboration with 26 Historically Black Colleges and Universities\, Merck\, Sanofi\, Amgen\, Alnylam\, the Global Black Economic Forum\, the National Medical Association\, Thurgood Marshall College Fund\, Coursera\, Advarra\, Virb and BeeKeeperAI. \n\n\n\n\n\n\n\n\n\n Janssen Pharmaceuticals \n\n\n\nJanssen’s “Research Includes Me” initiative seeks to identify needs\, build trust and break down barriers to access with a focus on traditionally underrepresented communities by providing educational materials\, addressing misperceptions\, hosting community events and connecting Patients to clinical research opportunities. Staci Hargraves\, Vice President of Portfolio Delivery Operations\, Global Development\, will share how Janssen partnered with industry groups\, such as the Society of Clinical Research Sites Diversity Awareness Program and Transcelerate’s Diversity in Clinical Trials workstream\, to develop programs and tools that foster better Patient experiences and care. \n\n\n\n\n\n\n\n\nRegister for FREE and join us for this very important conversation. Come ready to ask questions and share your own organization’s initiatives. It’s about coming together to make a difference and to ensure that “No Patient is ever left behind”.
URL:https://bionj.org/event/bionj-health-equity-in-clinical-trials-best-practices-webinar/
LOCATION:NJ
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/08/HECT-Best-Practices-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230913T083000
DTEND;TZID=America/New_York:20230913T153000
DTSTAMP:20260503T105004
CREATED:20230309T001446Z
LAST-MODIFIED:20230912T095135Z
UID:7057-1694593800-1694619000@bionj.org
SUMMARY:2023 BioNJ Manufacturing Briefing
DESCRIPTION:Registration is now closed. Please email MCarapucci@BioNJ.org to be added to our waiting list. \n\n\n\n\n\n\n\nRising to the Challenge: Manufacturing & Supplying Therapies in Today’s Reality\n\n\n\nWednesday\, September 13\, 2023 • 8:30 a.m.-3:30 p.m.\n\n\n\nRutgers University\, Busch Campus Student Center • 604 Bartholomew Road\, Piscataway\, NJ 08854 \n\n\n\n\nBecome a Sponsor\n\n\n\n\nBiopharma manufacturing has been evolving rapidly. Join us on September 13 for BioNJ’s Manufacturing Briefing where you’ll hear from and engage with thought leaders on timely and important topics affecting the industry\, such as Controlling the Cost of Goods; Digital\, Automation and AI in Biotech Manufacturing; and Strategic Partnerships with CMOs and CDMOs. Plus\, be on hand for… \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nStay after the program to tour Rutgers Pharma Manufacturing Facility ─ The two-story\, state-of-the-art continuous manufacturing lab is a $2 million dollar facility built with funding from the National Science Foundation that is providing biopharmaceutical manufacturers with an alternative to traditional batch processing\, including efficiencies that improve quality\, consistency\, production speed and cost. (Tour is on a first-come\, first-serve basis and number of participants is limited.) \n\n\n\nBe sure to forward this email to colleagues and customers who could also benefit from these topical discussions and perspectives! Registration is $95 for BioNJ Members and $175 for Future Members. Click here to register.
URL:https://bionj.org/event/bionj-manufacturing-briefing/
LOCATION:Rutgers University\, Busch Campus Student Center\, 604 Bartholomew Road\, Piscataway\, New Jersey\, 08854\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/03/Manufacturing-Briefing-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230830T000000
DTEND;TZID=America/New_York:20230830T235959
DTSTAMP:20260503T105004
CREATED:20230719T124306Z
LAST-MODIFIED:20230901T133815Z
UID:7824-1693353600-1693439999@bionj.org
SUMMARY:2023 TIE Women's Pitch Competition
DESCRIPTION:*This is not a BioNJ-hosted event. \n\n\n\n\n\n\n\n\n\n Aug 30\, 2023 \n\n\n\n 06:00 PM – 09:00 PM (America/New_York) \n\n\n\n New Jersey Bioscience Center\, 675\,U.S. 1 \n\n\n\n North Brunswick Township\,United States \n\n\n\n $25 onwards \n\n\n\n\nRegister
URL:https://bionj.org/event/2023-tie-womens-pitch-competition/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230706T000000
DTEND;TZID=America/New_York:20230706T235959
DTSTAMP:20260503T105004
CREATED:20230208T131308Z
LAST-MODIFIED:20230209T180810Z
UID:6428-1688601600-1688687999@bionj.org
SUMMARY:On Helix - New Horizons for Bio Innovation
DESCRIPTION:www.onhelix.com \n\n\n\n\n\nThis one-day conference will address key bio innovation trends\, from developments in life science and technology research to their translation into new diagnostics\, prevention tools or treatments. \n\n\n\nDelegates and Supporters will connect with the One Nucleus network to explore New Horizons for Bio Innovation. \n\n\n\nON Helix Key Benefits: \n\n\n\n\nHigh content mix of plenary talks and panels from key opinion leaders\n\n\n\nNetworking with 250+ delegates on the day\n\n\n\nOption to arrange 1 to 1 virtual meetings with in-person and digital only delegates\n\n\n\nThe ON Helix Fringe events including digital Innovation Workshops for further technical and business insights and additional in-person networking opportunities \n\n\n\nThe Innovation Support Hub Exhibition\, to showcase the most innovative early-stage life science companies as well as the innovation supporters from the network
URL:https://bionj.org/event/on-helix-new-horizons-for-bio-innovation/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230613T083000
DTEND;TZID=America/New_York:20230613T150000
DTSTAMP:20260503T105004
CREATED:20230221T135743Z
LAST-MODIFIED:20230614T144314Z
UID:6699-1686645000-1686668400@bionj.org
SUMMARY:2023 HR Conference
DESCRIPTION:Tuesday\, June 13\, 2023\, 8:30 a.m.-3:00 p.m.Kean University\, 1075 Morris Avenue\, Union\, NJ\n\n\n\nREGISTRATION FOR THIS EVENT IS NOW CLOSED. \n\n\n\nBioNJ’s 10th Annual HR Conference is taking place at Kean University on June 13. Come ready to connect with other life sciences HR professionals\, learn from industry experts on issues affecting your organization and leave with best practices that will enable you to position your company and your employees for success.  \n\n\n\nJoin the BioNJ HR community for answers\, insights and a chance to contribute. Knowledge is power and collaboration is crucial in creating new opportunities and growing the ecosystem. \n\n\n\n\n\n\n\n\n\n\n\nAttendees receive a copy of Melissa Swift’s book\, “Work Here Now: Think Like a Human and Build a Powerhouse Workplace.” \n\n\n\n\n\n \n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\nPlus\, interactive workshops\, a closing Keynote and lots of networking! \n\n\n\nCome ready to gather new and creative ideas\, strategies and tactics for how to navigate today’s HR challenges and opportunities in the life sciences sector.  \n\n\n\nRegistration is $175 for BioNJ Members and $275 for Future Members. 
URL:https://bionj.org/event/bionj-hr-conference/
LOCATION:Kean University\, 1075 Morris Ave\, Union\, NJ\, 07083\, United States
CATEGORIES:BioNJ Event,Past Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230605T000000
DTEND;TZID=America/New_York:20230608T235900
DTSTAMP:20260503T105004
CREATED:20230308T185210Z
LAST-MODIFIED:20230308T192501Z
UID:6996-1685923200-1686268740@bionj.org
SUMMARY:BIO International Convention
DESCRIPTION:Register Today!\n\n\n\n\nStand Up for Science at BIO 2023\n\n\n\nJune 5-8\, 2023\n\n\n\nStand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire\, honor\, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future. \n\n\n\nBIO One-on-One Partnering ™\n\n\n\nThe BIO International Convention attracts 14\,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. \n\n\n\nEngaging Programming\n\n\n\nInnovative programming around the current and future state of biotech. Including areas like therapeutic frontiers\, the business of biotech\, regulatory and policy outlooks\, and human capital.
URL:https://bionj.org/event/bio-international-convention/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, Massachusetts\, 02210\, United States
CATEGORIES:Industry Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230417T073000
DTEND;TZID=America/New_York:20230421T053000
DTSTAMP:20260503T105004
CREATED:20230113T182441Z
LAST-MODIFIED:20230817T131241Z
UID:5792-1681716600-1682055000@bionj.org
SUMMARY:2023 BioPartnering Conference
DESCRIPTION:PARTNERING FOR POSSIBILITY\n\n\n\n\n\nIN-PERSON PARTNERING\, EDUCATION & NETWORKING: Tuesday\, April 18\, 2023 | 7:30 a.m.-5:45 p.m.The Palace at Somerset Park\, Somerset\, NJ 08873Virtual Partnering: Monday\, April 17 & Wednesday-Friday*\, April 19-21\, 2023Registration for BioNJ Members is $395 and $495 for Future Members. *Full Conference Registration Required. \n\n\n\n\n\n\nAdd to Calendar\n\n\n\nPresenting Companies\n\n\n\nSponsor\n\n\n\n\n\n\n\n\nBack in person after three years\, BioNJ’s BioPartnering Conference will bring together over 500 life sciences executives\, investors\, academic collaborators and business development professionals for networking\, a full week of 1-1 partnering\, company and start-up pitch presentations\, exhibits and plenary sessions. Plus\, a highly anticipated networking reception offers the perfect opportunity to connect with future partners and investors! \n\n\n\nAttracting attendees from around the globe\, BioNJ’s BioPartnering Conference was created to foster productive collaborations and partnerships\, facilitate investment opportunities and bolster medical innovation. \n\n\n\nHighlights from BioNJ’s 2022 BioPartnering Conference: \n\n\n\n\nNearly 550 attendees from 18 states\, 11 countries as well as the District of Columbia\n\n\n\n53 company and start-up pitch presentations (see full eligibility requirements below)\n\n\n\n11 Academic and Research Institutions represented\n\n\n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\n                \n                \n                            \n                            \n                    \n            \n    \n    \n    \n\n\n\n\n\n\n\n\n\n\nCompany and Start-Up Pitch Presentations\nThere are two different presentation tracks. When completing the application\, you will be asked to answer some qualifying questions which will determine which presentation track you are eligible for. A limited number of presentation slots are available per track. The application submission process will begin on January 17\, 2023\, with a deadline of February 24\, 2023.  Please review the eligibility criteria below. \n\n\n\nAccepted companies will be responsible for their registration fees. There is no additional fee to apply or present. Applicants will be notified by March 10\, 2023 if they are selected. Qualified applicants not selected to present will have the opportunity to display company information in our Poster Symposium Showcase. \n\n\n\nAdditional Requirements for Applicants: \n\n\n\nSelected 10-minute Company Presenters will have a 60-minute mandatory Review Session with a selected team of BioNJ Member companies in preparation for the conference (Date To Be Announced). \n\n\n\nSelected 2-minute Start-Up Pitch Presenters will have a mandatory Virtual Pitch Presentation Workshop in late March (Date To Be announced).   \n\n\n\n*If you have not completed a Series-A funding\, please apply for the Start-Up Pitch Presentation Track \n\n\n\nAPPLICATION SUBMISSION PROCESS CLOSED. \n\n\n\n\nCompany Presentation (10-minute presentations) Eligibility Requirements\n\nHas minimally completed Series-A funding before February 24\, 2023 or you are in the process of raising $5 million or more in Series-A funding.\n\n\n\nPre-revenue to marketed product\n\n\n\nPrivate (minimum series A round*) or public (micro-\, small- and mid-cap) life sciences company or technology company directly impacting life sciences innovation in one of the following research and development-based categories:DevicesDiagnosticsDigital Medicine/Medtech TechnologiesHealth IT (AI\, Big Data\, Bioinformatics\, Machine Learning)R&D Discovery and Enabling Technologies\n\nTherapeutics\n\n\n\n\n\n\nAPPLICATION SUBMISSION PROCESS CLOSED. \n\n\n\n\nStart-Up Pitch Presentation (2-minute presentations) Eligibility Requirements\n\nHas not completed a series A round before February 24\, 2023\n\n\n\nHas filed for IP protection before February 24\, 2023\n\n\n\nActively working to secure a seed round up to $5 million investment\n\n\n\nLife sciences company or technology company directly impacting life sciences innovation in one of the following research and development-based categories:DevicesDiagnosticsDigital Medicine/Medtech TechnologiesHealth IT (AI\, Big Data\, Bioinformatics\, Machine Learning)R&D Discovery and Enabling Technologies\n\nTherapeutics\n\n\n\n\n\n\nAPPLICATION SUBMISSION PROCESS CLOSED. \n\n\n\n\n1:1 Partnering\nThis year’s BioPartnering Conference offers five full days of 1:1 partnering! The One-on-One Partnering system\, opening mid-March\, will allow you to set up in-person partnering meetings for Tuesday\, April 18\, as well as virtual meetings for Monday\, April 17\, and Wednesday\, April 19\, through Friday\, April 21. \n\n\n\nContact Ann Wieczkowski at AWieczkowski@BioNJ.org if you have any questions about using the 1:1 partnering platform. \n\n\n\n\nSponsorship\nThere are many Sponsorship Opportunities available! Contact Cheri Hennessy\, Vice President\, Member Engagement and Strategic Partnerships\, at 609-890-3185 or CHennessy@BioNJ.org to design a Sponsorship Package that meets your needs! \n\n\n\n\nRegistration Information\nRegistration for BioNJ Members is $395 and $495 for Future Members. \n\n\n\n\nGeneral Questions about BioPartnering Conference?\nPlease contact Pavita Howe\, Vice President\, Innovation and Entrepreneurship at 609-890-3185 or Phowe@BioNJ.org. \n\n\n\n\n\nThank You to Our Sponsors \n\n\n\n\n\n\nThank You to Our Supporting Partners
URL:https://bionj.org/event/biopartnering-conference/
LOCATION:The Palace at Somerset Park\, 333 Davidson Ave\, Somerset Park\, NJ\, 08873\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange,Past Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230330T180000
DTEND;TZID=America/New_York:20230330T200000
DTSTAMP:20260503T105004
CREATED:20230316T135244Z
LAST-MODIFIED:20230614T144440Z
UID:7082-1680199200-1680206400@bionj.org
SUMMARY:Cell and Gene Therapy Manufacturing: Are We There Yet?
DESCRIPTION:Bristol-Myers Squibb3401 Princeton PikeLawrence Twp.\, NJ 08648 \n\n\n\nCell and Gene Therapy is becoming an important area of biopharmaceuticals as products have been commercialized. In addition\, industry has significant amount of clinical phase activity. This event will provide an update on the new and upcoming field of cell and gene therapy relative to current and future manufacturing approaches. \n\n\n\n\nRegister Today!\n\n\n\n\nRobert Lechich from Global OT-IT Quality Services will provide a short presentation and moderate a panel discussion of industry leaders to cover manufacturing\, facilities\, quality\, technical support and automation perspectives. \n\n\n\nMembers: $75Non-Members: $100Student Members and Chapter Academic Advisor: $10Emerging Leaders: $50Gold Sponsor: $500 (includes 2 free tickets to event)Event Sponsor: $300 (includes 1 free ticket to event)
URL:https://bionj.org/event/cell-and-gene-therapy-manufacturing-are-we-there-yet/
LOCATION:NJ
CATEGORIES:Industry Event,Past Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230321T120000
DTEND;TZID=America/New_York:20230321T130000
DTSTAMP:20260503T105004
CREATED:20230215T200905Z
LAST-MODIFIED:20240711T121846Z
UID:6523-1679400000-1679403600@bionj.org
SUMMARY:What Life Sciences CFOs Need to Know in 2023: A Life Sciences CFO Roundtable
DESCRIPTION:Register Today for Free!\n\n\n\n\n\n\n\n\nAccording to the 2023 BDO Life Sciences CFO Outlook Survey\, the life sciences industry is evolving from its pandemic gold-rush years. While 2022 revenues were quite strong\, companies are facing increasing pressure to manage cash and meet investor expectations.  \n\n\n\nJoin us for a discussion with life sciences financial leaders to learn how they are: \n\n\n\n\nPreserving cash in the face of declining valuations\n\n\n\nFocusing R&D and expanding manufacturing capacity\n\n\n\nEntering deals and partnerships to secure new assets\, create development and production synergies and secure cash\n\n\n\n\nWho should attend: \n\n\n\nPrivate and Public Company Controllers\, Vice Presidents of Finance\, CFOs\, R&D Company CEOs\, Finance Team Members and Legal Counsel and Others who are interested in the life sciences ecosystem \n\n\n\nPanelists:\n\n\n\n\n\nSusan BlumChief Financial OfficerMelinta Therapeutics\n\n\n\n\n\nBrian LenzExecutive Vice President& Chief Financial OfficerADMA Biologics\n\n\n\n\n\nBob MeccaSr. Vice President\, FinanceBeiGene\n\n\n\n\n\nDaphne QuimiChief Financial OfficerAmicus Therapeutics\n\n\n\n\n\nModerator:  Lance MinorPrincipal\, Life Sciences National Co-Leader BDO\n\n\n\n\n\n\n\n\n\nThe life sciences industry is changing. Learn what opportunities and risks could await life sciences companies in 2023 and how to plan ahead. \n\n\n\nWe hope to see you on March 21 for this FREE educational webinar! Click here to register. \n\n\n\n\n\n\n\n\n\n\n\n				\n					\n				\n			\n\n\nFeature Title\n\n\n\nThis is a feature block that you can use to highlight features. \n\n\n\n\n\n				\n					\n				\n			\n\n\nFeature Title\n\n\n\nThis is a feature block that you can use to highlight features.
URL:https://bionj.org/event/what-life-sciences-cfos-need-to-know-in-2023-a-life-sciences-cfo-roundtable/
LOCATION:NJ
CATEGORIES:BioNJ Event
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2023/02/Brian-Lenz.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230228T170000
DTEND;TZID=America/New_York:20230228T200000
DTSTAMP:20260503T105004
CREATED:20230125T155047Z
LAST-MODIFIED:20230614T144427Z
UID:6146-1677603600-1677614400@bionj.org
SUMMARY:2023 New Jersey Rare Disease Day
DESCRIPTION:One of the greatest challenges individuals living with a rare disease\, their families and Patient advocates have is finding and accessing information and resources to help them advocate for themselves and their loved ones\, as well as to raise awareness of issues facing others in the community. To help alleviate these daily burdens and ensure individuals and advocates can navigate local and state-based resources\, NORD New Jersey Rare Action Network is hosting a State Resource Fair for the rare disease community to coincide with Rare Disease Day. There is no cost to participants to attend this event. \n\n\n\nTaking place at the Make-A-Wish Castle\, The Samuel & Josephine Plumeri Wishing Place\, 1384 Perrineville Road\, Monroe Township\, NJ\, click here to register.
URL:https://bionj.org/event/2023-new-jersey-rare-disease-day/
LOCATION:Make-A-Wish Castle\, The Samuel & Josephine Plumeri Wishing Place\, 1384 Perrineville Road\, Monroe Township\, New Jersey\, 08831\, United States
CATEGORIES:Industry Event,Past Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230202T164500
DTEND;TZID=America/New_York:20230202T203000
DTSTAMP:20260503T105004
CREATED:20221216T163613Z
LAST-MODIFIED:20230817T124845Z
UID:3775-1675356300-1675369800@bionj.org
SUMMARY:2023 Annual Dinner Meeting & Innovation Celebration
DESCRIPTION:The Presentation of the Dr. Sol J. Barer Award forVision\, Innovation and Leadership to David S. Perlin\, Ph.D.\n\n\n\n\n\nRegister Today!\n\n\n\n\n\nBecome a Sponsor\n\n\n\n\n\nThursday\, February 2\, 2023 • Hilton East Brunswick\, East Brunswick\, NJNetworking Reception & Dinner Program: 4:45 p.m. – 8:30 p.m.Dessert Reception: 8:30 p.m. – 9:30 p.m.\n\n\n\nRegister today and join us for BioNJ’s 30th Annual Dinner Meeting and Innovation Celebration\, taking place Thursday\, February 2\, 2023\, at the Hilton East Brunswick\, where we’ll celebrate the extraordinary innovation happening in the Garden State.   \n\n\n\nMany surprises are in store for an evening of inspiration and camaraderie. Kicking off the start of the New Year\, BioNJ’s Annual Dinner Meeting & Innovation Celebration features:  \n\n\n\n\nNetworking with biopharmaceutical professionals\, government officials\, academic leaders and professional service providers\n\n\n\nThe presentation of the Dr. Sol J. Barer Award to Dr. David Perlin\, Chief Scientific Officer and Executive Vice President of the Hackensack Meridian Center for Discovery and Innovation by Dr. Barer himself \n\n\n\nThe Innovator Awards honoring New Jersey companies that received a new FDA drug approval in 2022\n\n\n\nThe presentation of the Annual Heart of BioNJ Awards\n\n\n\nA Cocktail Hour\, Dinner Program and Dessert Reception\n\n\n\n\nDon’t miss this memorable evening celebrating New Jersey’s life sciences ecosystem and the Patients who inspire us. Space is limited. So don’t delay. Reserve a table for your Team today. Visit www.BioNJ.org for more information. \n\n\n\n\n\n\n\nCelebrating Our 30th Anniversary!\n\n\n\nBioNJ’s Annual Dinner Meeting & Innovation Celebration will bring together hundreds of biopharmaceutical company executives\, professional service providers\, government officials\, academic leaders and others. Register now and plan to join us for an inspirational evening featuring the acclaimed Innovator Awards\, the presentation of the Heart of BioNJ Awards and plenty of networking over a cocktail reception\, dinner program and dessert reception! Registration for BioNJ Members is $490. Future Member pricing is $550. \n\n\n\nContact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship opportunities. Call (609) 890-3185 with any questions. \n\n\n\nThank You to Our Sponsors
URL:https://bionj.org/event/adm/
LOCATION:Hilton East Brunswick\, 3 Tower Center Blvd\, East Brunswick\, NJ\, 08816\, United States
CATEGORIES:BioNJ Event,Entrepreneurs-Exchange,Past Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230124T060000
DTEND;TZID=America/New_York:20230124T150000
DTSTAMP:20260503T105004
CREATED:20221227T235001Z
LAST-MODIFIED:20221228T132549Z
UID:5405-1674540000-1674572400@bionj.org
SUMMARY:How to Optimize Your R&D Tax Credits with ADP
DESCRIPTION:Companies performing qualified R&D activities can be rewarded by lucrative federal and state tax incentives in the form of R&D tax credits\, even if their efforts were not successful. This is particularly true for small-to-midsized BIO and state life science association members. \n\n\n\nBIO recently partnered with ADP to provide discounted R&D tax credit services to life science companies. Join us for a complimentary webinar to learn how to maximize this new BIO-ADP tax credit offering.  \n\n\n\nWe will also cover: \n\n\n\n\nEligible R&D tax credit activities\n\n\n\nWhere additional state R&D benefits may exist\n\n\n\nRecent changes to the R&D tax credit under the Inflation Reduction Act (IRA)\n\n\n\nIndustry examples\n\n\n\nADP R&D tax credit project lifecycle\n\n\n\n\nSpeakers: \n\n\n\n\nCameron Arterton\, VP Emerging Companies & Capital Formation\, BIO\n\n\n\n Sanjiv Gaitonde\, Senior Tax Director\, ADP\n\n\n\nNicholas Squicciarini\, Senior Tax Manager\, ADP\n\n\n\n\n\nRegister
URL:https://bionj.org/event/how-to-optimize-your-rd-tax-credits-with-adp/
LOCATION:NJ
CATEGORIES:Industry Event
END:VEVENT
END:VCALENDAR